TaiGen Biopharmaceuticals Holdings Limited announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 4.799 million compared to TWD 4.954 million a year ago. Operating loss was TWD 66.904 million compared to TWD 66.743 million a year ago. Net loss was TWD 102.750 million compared to TWD 124.573 million a year ago. Basic loss per share was TWD 0.14 compared to TWD 0.17 a year ago. For the nine months, sales was TWD 13.497 million compared to TWD 24.932 million a year ago. Operating loss was TWD 193.391 million compared to TWD 174.330 million a year ago. Net loss was TWD 96.375 million compared to TWD 247.460 million a year ago. Basic loss per share was TWD 0.13 compared to TWD 0.35 a year ago.